Literature DB >> 7389249

Interindividual differences in amitriptyline demethylation.

D E Rollins, G Alván, L Bertilsson, J R Gillette, B Mellström, F Sjöqvist, L Träskman.   

Abstract

Amitriptyline (AT) and its demethyl metabolite nortriptyline (NT) were given orally and intramuscularly to 6 normal subjects, and the areas under the blood concentration--time curves (AUC) were calculated. The mean unbound fraction of AT and NT in plasma was 5.4% and 8.3%, respectively. The blood-plasma ratio of NT was nearly double that of AT, which was close to unity. The mean systemic availability of oral relative to intramuscular AT and NT was 43% and 61%. The calculated mean oral blood clearance of AT as measured by dose (oral)/AUC was 1.6 1/min. The demethylation of orally administered AT varied considerably between the 6 individuals (from 25% to 89%) and correlated with oral drug clearance. Demethylation was estimated from the AUC applied to the NT metabolite. The estimated oral clearance of AT from demethylation ranged from 0.21 to 1.80 1/min.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7389249     DOI: 10.1038/clpt.1980.140

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN: 0009-9236            Impact factor:   6.875


  18 in total

Review 1.  Clinical significance of pharmacokinetic models of hepatic elimination.

Authors:  D J Morgan; R A Smallwood
Journal:  Clin Pharmacokinet       Date:  1990-01       Impact factor: 6.447

Review 2.  Discrepancies between pharmacokinetic studies of amitriptyline.

Authors:  P Schulz; P Dick; T F Blaschke; L Hollister
Journal:  Clin Pharmacokinet       Date:  1985 May-Jun       Impact factor: 6.447

3.  Biotransformation of amitriptyline in depressive patients: urinary excretion of seven metabolites.

Authors:  B Vandel; M Sandoz; S Vandel; G Allers; R Volmat
Journal:  Eur J Clin Pharmacol       Date:  1982       Impact factor: 2.953

4.  Metabolite to parent drug concentration ratio as a function of parent drug extraction ratio: cases of nonportal route of administration.

Authors:  E A Lane; R H Levy
Journal:  J Pharmacokinet Biopharm       Date:  1981-08

5.  Role of oxidation polymorphism on blood and urine concentrations of amitriptyline and its metabolites in man.

Authors:  A E Balant-Gorgia; P Schulz; P Dayer; L Balant; A Kubli; C Gertsch; G Garrone
Journal:  Arch Psychiatr Nervenkr (1970)       Date:  1982

6.  Overdosage of antidepressants: clinical and pharmacokinetic aspects.

Authors:  O L Pedersen; L F Gram; C B Kristensen; M Møller; P Thayssen; M Bjerre; P Kragh-SøRensen; N A Klitgaard; E Sindrup; P Hole; M Brinklø
Journal:  Eur J Clin Pharmacol       Date:  1982       Impact factor: 2.953

7.  Plasma protein binding of perazine and amitriptyline in psychiatric patients.

Authors:  M Brinkschulte; H J Gaertner; H W Schied; U Breyer-Pfaff
Journal:  Eur J Clin Pharmacol       Date:  1982       Impact factor: 2.953

8.  The demethylation of amitriptyline: a cross-over study of steady-state plasma levels of amitriptyline and nortriptyline in depressed patients.

Authors:  J E Burch
Journal:  Psychopharmacology (Berl)       Date:  1983       Impact factor: 4.530

9.  The demethylation of amitriptyline administered by oral and intramuscular routes.

Authors:  J E Burch; D G Herries
Journal:  Psychopharmacology (Berl)       Date:  1983       Impact factor: 4.530

Review 10.  Active hydroxymetabolites of antidepressants. Emphasis on E-10-hydroxy-nortriptyline.

Authors:  C Nordin; L Bertilsson
Journal:  Clin Pharmacokinet       Date:  1995-01       Impact factor: 6.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.